PU Prevention is now a reality, at-scale, and in-year. What we've learned since 2009. Implications for patients, practitioners, providers, payers, the care pathway and research

Unlike most areas in medicine, objective evidence of patients’ status has been absent from the practice of wound care. Biometric sensing technology, CE Marked since 2014, has introduced skin and tissue status data in addition to subjective assessment.  The use of these data has allowed practitioners to achieve their long-desired goal of pressure ulcer prevention. This session details the work of 11 disparate sites (n=957) representing a variety of settings and patient cohorts who used this technology in a prevention-focused care pathway to prevent PUs.  We present what they did to (in 7 out of 11 of the cases) achieve zero HAPUs. The methods employed by the sites are not-obvious. At a minimum, they inform and advance the discussion of what PU prevention is and how it is achieved. 
More fundamentally, in the course of preventing HAPUs using this technology’s data, practitioners have learned that: the definition of prevention must include keeping the skin intact; too few of the right patients and too many of the wrong patients are receiving preventative measures; preventative actions are provided universally to the whole body, while anatomically specific interventions at the sites, where PUs develop, are occurring too late in the damage cascade; and, the current care pathway is not optimally designed for the achievement of prevention. Using real-world clinical data, cost and operational analyses we conclude with implications for patients, practitioners, providers, payers, the care pathway and research of realizing PU prevention at scale.